These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1544372)

  • 1. Retinoic acid-induced differentiation of a nontumorigenic embryonal carcinoma cell mutant created through retroviral insertion.
    Dietrich J; Shin HS; McCormick PJ
    Exp Cell Res; 1992 Apr; 199(2):305-13. PubMed ID: 1544372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the factors involved in the retinoic acid-induced differentiation of a retinoid-hypersensitive embryonal carcinoma cell mutant.
    Dietrich JM; McCormick PJ
    Exp Cell Res; 1994 Feb; 210(2):201-8. PubMed ID: 8299717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A parallel association between differentiation and induction of galectin-1, and inhibition of galectin-3 by retinoic acid in mouse embryonal carcinoma F9 cells.
    Lu Y; Amos B; Cruise E; Lotan D; Lotan R
    Biol Chem; 1998 Nov; 379(11):1323-31. PubMed ID: 9865605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementation analyses of differentiation-defective embryonal carcinoma cells.
    McCue PA; Gubler ML; Maffei L; Sherman MI
    Dev Biol; 1984 Jun; 103(2):399-408. PubMed ID: 6144604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the cellular retinoid-binding proteins and their messenger ribonucleic acids during P19 embryonal carcinoma cell differentiation induced by retinoic acid.
    Wei LN; Blaner WS; Goodman DS; Nguyen-Huu MC
    Mol Endocrinol; 1989 Mar; 3(3):454-63. PubMed ID: 2546063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression in visceral endoderm: a comparison of mutant and wild-type F9 embryonal carcinoma cell differentiation.
    Rogers MB; Watkins SC; Gudas LJ
    J Cell Biol; 1990 May; 110(5):1767-77. PubMed ID: 1692330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic adenosine monophosphate-mediated induction of F9 teratocarcinoma differentiation in the absence of retinoic acid.
    Goldstein B; Rogelj S; Siegel S; Farmer SR; Niles RM
    J Cell Physiol; 1990 May; 143(2):205-12. PubMed ID: 1692026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective post-translational modification of collagen IV in a mutant F9 teratocarcinoma cell line is associated with delayed differentiation and growth arrest in response to retinoic acid.
    Wang SY; Roguska MA; Gudas LJ
    J Biol Chem; 1989 Sep; 264(26):15556-64. PubMed ID: 2549067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation-defective mutants of mouse embryonal carcinoma cells: response to hexamethylenebisacetamide and retinoic acid.
    McCue PA; Matthaei KI; Taketo M; Sherman MI
    Dev Biol; 1983 Apr; 96(2):416-26. PubMed ID: 6299821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commitment to differentiation induced by retinoic acid in P19 embryonal carcinoma cells is cell cycle dependent.
    Mummery CL; van den Brink CE; de Laat SW
    Dev Biol; 1987 May; 121(1):10-9. PubMed ID: 2883052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of F9 cell differentiation by transient exposure to retinoic acid.
    Dong JM; Li F; Chiu JF
    Biochem Biophys Res Commun; 1990 Jul; 170(1):147-52. PubMed ID: 1695505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of retinoic acid nuclear receptors in the mouse embryonal carcinoma cell line PCC7-Mz1.
    Heiermann R; Rentrop M; Lang E; Maelicke A
    FEBS Lett; 1992 Nov; 312(1):75-9. PubMed ID: 1385214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proto-oncogene expression during retinoic acid-induced neural differentiation of embryonal carcinoma cells.
    Nakamura KD; Hart RW
    Mech Ageing Dev; 1989 Apr; 48(1):53-62. PubMed ID: 2725075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse cellular retinoic acid binding protein: cloning, complementary DNA sequence, and messenger RNA expression during the retinoic acid-induced differentiation of F9 wild type and RA-3-10 mutant teratocarcinoma cells.
    Stoner CM; Gudas LJ
    Cancer Res; 1989 Mar; 49(6):1497-504. PubMed ID: 2538228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two transient increases in c-myc gene expression during neuroectodermal differentiation of mouse embryonal carcinoma cells.
    St-Arnaud R; Nepveu A; Marcu KB; McBurney MW
    Oncogene; 1988 Nov; 3(5):553-9. PubMed ID: 3078960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of differentiation in PA-1 human teratocarcinoma cells after N-ras oncogene-induced tumorigenicity.
    Tainsky MA; Yim SO; Krizman DB; Kannan P; Chiao PJ; Mukhopadhyay T; Buettner R
    Oncogene; 1991 Sep; 6(9):1575-82. PubMed ID: 1681491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection and characterization of F9 teratocarcinoma stem cell mutants with altered responses to retinoic acid.
    Wang SY; Gudas LJ
    J Biol Chem; 1984 May; 259(9):5899-906. PubMed ID: 6325455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression and localization of urokinase-type plasminogen activator and its type 1 inhibitor are regulated by retinoic acid and fibroblast growth factor in human teratocarcinoma cells.
    Tienari J; Alanko T; Lehtonen E; Saksela O
    Cell Regul; 1991 Apr; 2(4):285-97. PubMed ID: 1905574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of nuclear retinoic acid receptors in wild-type and mutant embryonal carcinoma PCC4.aza1R cells.
    Nervi C; Vollberg TM; Grippo JF; Lucas DA; George MD; Sherman MI; Shudo K; Jetten AM
    Cell Growth Differ; 1990 Nov; 1(11):535-42. PubMed ID: 1965138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of a nontumorigenic embryonal carcinoma cell line.
    McCormick PJ; Shin HS
    Exp Cell Res; 1990 Aug; 189(2):183-8. PubMed ID: 2164481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.